← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2022Last known activity
Feb 28, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 5 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (13)
- NCT06823752OfficialPhase 2Feb 28, 2025
- NCT06802913OfficialEarly Phase 1Feb 28, 2025
- NCT06802913Lead sponsorEarly Phase 1Feb 28, 2025
- NCT06823752Sponsor investigatorPhase 2Feb 28, 2025
- NCT06802913Sponsor investigatorEarly Phase 1Feb 28, 2025
- NCT06823752Lead sponsorPhase 2Feb 28, 2025
- NCT06801379OfficialEarly Phase 1Feb 1, 2025
- NCT06801379Lead sponsorEarly Phase 1Feb 1, 2025
- NCT06801379Sponsor investigatorEarly Phase 1Feb 1, 2025
- NCT05344170Lead sponsorPhase 1/Phase 2Aug 24, 2022
- NCT05344170Overall official - principal investigatorPhase 1/Phase 2Aug 24, 2022
- NCT05253417CollaboratorPhase 2May 1, 2022
- NCT05253417Overall official - principal investigatorPhase 2May 1, 2022
Details
- Last known activity
- Feb 28, 2025